United States · FDA National Drug Code directory
Mirtazapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66993-608_e1a19354-1c97-49ed-8ec9-bb895dbe69f3
- Product NDC
- 66993-608
- Form
- TABLET, FILM COATED
- Composition / generic term
- Mirtazapine
- Labeler
- Prasco Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230901
- Source listing expiry
- 20261231
Source-listed ingredients
- MIRTAZAPINE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (66993-608-04) · 66993-608-04
- 30 TABLET, FILM COATED in 1 BOTTLE (66993-608-30) · 66993-608-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →